Pharmacovigilance based on prescription databases

Pharmacology and Toxicology, Supplement

Volumn 86, Issue 1, 2000, Pages 13-15

  Gram, Lars F ^a   Hallas, Jesper ^a   Andersen, Morten ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DATA BASE; DRUG EXPOSURE; DRUG INFORMATION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HEALTH HAZARD; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0033922330     PISSN: 09019936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2000.d01-4.x     Document Type: Conference Paper

References (23)

1. Barbone, F., A. D. MacMahon, P. G. Davey, A. D. Morris, I. C. Reid, D. G. McDevitt & T. M. MacDonald: Association of road-traffic accidents with bezodiazepine use. Lancet 1998, 352, 1331-1336.
2. Bjerrum, L. & U. Bergman: What predicts the number of different drugs prescribed in general practice. 3rd, EACPT Congress, Jerusalem, 3-8 October 1999.
3. British Thoracic Society and others: Guidelines for the management of asthma: A summary. Brit. Med. J. 1993, 306, 776-782.
4. Dunn, N., I. White, S. Freemantle & R. Mann: The role of prescribing and referral bias in studies of the association between third generation oral contraceptives and increased risk of thromboembolism. Pharmacoepidemiology and Drug Safety 1998, 7, 3-14.
5. Friedman, M. A., J. Woodcock, M. M. Lumpkin, A. E. Hass & L. J. Thompson: The safety of newly approved medicines. Do recent market removals mean there is a problem? JAMA 1999, 281, 1728-1734.
6. Gaist, D., M. Andersen & J. S. Schou: The use of population-based mortality and morbidity data in pharmacovigilance. A report on the pilot project "The incidence of serious diseases with frequent iatrogenic aetiology in European countries". An EC report, University of Copenhagen, Copehagen, 1994.
7. Gaist, D., J. Hallas, S. H. Sindrup & L. F. Gram: Is overuse of sumatriptan a problem? Eur. J. Clin. Pharmacol. 1996a, 50, 161-165.
8. Gaist, D., J. Hallas, N.-C. G. Hansen & L. F. Gram: Are young adults with asthma treated sufficiently with inhaled steroids? A population-based study of prescription data from 1991 and 1994. Brit. J. Clin. Pharmacol. 1996b, 41, 285-289.
9. Gaist, D., I. Tsiropoulos, S. H. Sindrup, J. Hallas, B. K. Rasmussen, J. Kragstrup & L. F. Gram: Inappropriate use of sumatriptan: population based register and interview study. Brit. Med. J. 1998, 316, 1352-1353.
10. Gram, L. F., P. Kragh-Sørensen, G. Isacsson & U. Bergman: Anti-depressants and suicide. Study did not consider treatment efficacy (letter). Brit. Med. J. 1995, 311, 55-56.
11. Gram, L. F., J.-U. Rosholm & J. Hallas: Facing the issue of drug interactions in elderly depressed patients. Int. Acad. Biomed. Drug Res. 1998, 13, 171-177.
12. Hallas, J. & N.-C. G. Hansen: Individual utilization of anti-asthma medication by young adults: A prescription database analysis. J. Int. Med. 1993, 234, 65-70.
13. Hallas, J.: Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology 1996, 7, 478-484.
14. Hallas, J. & P. Bytzer: Screening for drug related dyspepsia: an analysis of prescription symmetry. Eur. J. Gastroenterol. 1998, 10, 27-32.
15. Hallas, J.: Bivirkninger. In: Basal og klinisk farmukologi, 2nd ed., chapter 58, pp. 657-666. Ed.: J. P. Kampmann et al. FADL, Copenhagen 1999.
16. Hanrahan, J. P., P. W. Choo, W. Carlson, D. Greineder, G. A. Faich & R. Platt: Terfenadine-associated ventricular arrhythmias and QTc interval prolongation. A retrospective cohort comparison with other antihistamines among members of a health maintenance organization. Ann. Epidemiol. 1995, 5, 201-209.
17. Jick, S. S., A. D. Dean & H. Jick: Antidepressants and suicide. Brit. Med. J. 1995, 310, 215-218.
18. Leufkens, H. G. & J. Urquhart: Automated record linkage and other approaches to pharmacoepidemiology in The Netherlands. Chapter 17. In: Pharmacoepidemiology, 2nd ed. Ed.: B. L. Strom. John Wiley & Sons, Chichester, 1994, pp. 231-244.
19. Maclure, M.: The case-crossover design: a method for studying transient effects on the risk of acute events. Amer. J. Epidemiol. 1991, 133, 144-153.
20. Redelmeier, D. A. & R. J. Tibshirani: Association between cellular-telephone calls and motor vehicle collisions. New Eng.l J. Med. 1997, 336, 453-458.
21. Rosholm, J.-U., L. Bjerrum, J. Hallas, J. Worm & L. F. Gram: Polypharmacy and the risk of drug-drug interactions among Danish elderly. Dan. Med. Bull. 1998, 42, 210-213.
22. Schou, J. S.: Quelles sont les actions à mener pour aboutir à une uniformisation dans le domaine réglementaire? Europe Blanche XIV, 1992, pp. 60-63.
23. Strom, B. L.: Study designs available for pharmacoepidemiology studies. In: Pharmacoepidemiology, 2nd ed. Ed.: B. L. Strom, John Wiley & Sons, Chichester, 1994, pp. 15-27.